-
2025 COMB丨Professor Peng Yuan: Multi-Gene Testing Drives Personalized Treatment and Illuminates a New Era in Precision Breast Cancer Care
Conference Highlights: From Detection to Treatment Oncology Frontier: The 8th COMB has opened successfully. Could you summarize the key themes and highlights of this year’s meeting? Professor Peng Yuan:The Conference…
-
Professor Ping Zhang at COMB 2025: Breaking Through Endocrine Resistance—New Precision Pathways for HR+/HER2- Breast Cancer
01 Oncology Frontier: To begin, could you outline the current situation regarding endocrine resistance in HR+/HER2- breast cancer? Professor Ping Zhang:Endocrine resistance in HR+/HER2- breast cancer can be divided into…
-
Academician Xishan Hao: The Mission of Advancing Chinese Oncology and Building Academic Journal
Oncology Frontier: Having witnessed the evolution of oncology research in China, how do you view the past, present, and future of this discipline? Academician Xishan Hao:Oncology is both an ancient…
-
Professor Xiaowei Qi: Preferred Neoadjuvant Strategies in HER2-Positive Breast Cancer and Breakthrough Directions in TNBC Immunotherapy
TCbHP as the Preferred Neoadjuvant Strategy in HER2-Positive Breast Cancer Oncology Frontier:In the debate on “optimal neoadjuvant strategies for HER2-positive breast cancer,” you supported the TCbHP regimen. Could you explain…
-
Professors Xuening Ji & Yuhua Song: Rescue Therapy in TNBC—Which Immunotherapy Combination Should Be Preferred?
Key Arguments and Rationale Professor Xuening Ji: Chemotherapy as the Preferred Partner I believe chemotherapy remains the optimal partner for immunotherapy in the rescue treatment of advanced TNBC. These patients…
-
Professors Li Wang & Jianbin Li: Choosing Adjuvant Therapy for Intermediate-Risk HR+ Early Breast Cancer
Weighing the Options Professor Li Wang: Chemotherapy + AI as First Choice In my view, chemotherapy combined with AI remains the preferred adjuvant option for patients with intermediate-risk HR+/HER2− early…
Connecting Medical Expertise through Media